Arrowstreet Capital’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,391
Closed -$235K 1413
2022
Q3
$235K Buy
+1,391
New +$235K ﹤0.01% 1191
2020
Q4
Sell
-492
Closed -$229K 2447
2020
Q3
$229K Buy
+492
New +$229K ﹤0.01% 2181